Receptor density can be measured using techniques such as radioligand binding assays and immunohistochemistry. While these methods are typically performed in research settings, the results can inform clinical practice by identifying potential targets for therapeutic intervention. Nurses should be aware of these techniques to better understand the underlying mechanisms of the treatments they administer.
